Journals / Ankara Üniversitesi Tıp Fakültesi Mecmuası / 2022 / Cilt: 75 - Sayı: 2

Can Electrophysiological Studies Predict Multiple Sclerosis Prognosis?

Elektrofizyolojik Çalışmalar Multipl Skleroz Prognozunu Öngörebilir mi?

Pages
231–238
Publication Date
2022-10-10
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

There was a statistically significant difference between EDSS scores and the pathologies detected in both electrophysiological examinations (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: Multiple sclerosis (MS) is an autoimmune neurodegenerative disease with an unpredictable course.
📊
Key Findings & Data:MS lesions can affect the evoked potentials (EP) of electrophysiological studies.
💡
Conclusion & Impact:There was a statistically significant difference between EDSS scores and the pathologies detected in both electrophysiological examinations (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objectives: Multiple sclerosis (MS) is an autoimmune neurodegenerative disease with an unpredictable course. MS lesions can affect the evoked potentials (EP) of electrophysiological studies. In this study, we aimed to predict the prognosis of MS patients with electrophysiological parameters. Materials and Methods: MS patients with visual EP (VEP) and somatosensorial EP (SEP) were included in the study during two-year period. Demographic characteristics, MS type, attack numbers, current expanded disability status scales (EDSS), electrophysiological EP, blood tests, first cerebrospinal fluid (CSF) and magnetic resonance imaging (MRI) findings of the patients were evaluated. Results: Two hundred and fifty-nine MS patients were evaluated. There was a statistically significant difference between EDSS scores and the pathologies detected in both electrophysiological examinations (p

Özet

Amaç: Multipl skleroz (MS), prognozu öngörülemeyen otoimmün nörodejeneratif bir hastalıktır. MS lezyonları, elektrofizyolojik çalışmaların uyarılmış potansiyellerini (UP) etkileyebilir. Bu çalışmada elektrofizyolojik parametreleri kullanarak MS hastalarının prognozunu öngörmeyi amaçladık. Gereç ve Yöntem: İki yıl boyunca, vizüel UP (VUP) ve somatosensoryal UP (SUP) tetkikleri yapılmış olan MS hastaları çalışmaya dahil edildi. Hastaların demografik özellikleri, MS tipi, atak sayıları, muayene esnasındaki genişletilmiş engellilik durum skalaları (EDSS), elektrofizyolojik UP, kan testleri, ilk beyin omurilik sıvısı (BOS) ve manyetik rezonans görüntüleme (MRG) bulguları değerlendirildi. Bulgular: Toplam iki yüz elli dokuz MS hastası değerlendirildi. Her iki elektrofizyolojik inceleme için de, tespit edilen patolojik sonuçlar ile hastaların EDSS skorları arasında istatistiksel olarak anlamlı bir ilişki vardı (p

🔖

Cite This Article

Beton, Ö. E., Mungan, S. Ö. (2022). Can Electrophysiological Studies Predict Multiple Sclerosis Prognosis?. Ankara Üniversitesi Tıp Fakültesi Mecmuası, Cilt: 75 - Sayı: 2, 231–238. https://ajindex.com/articles/443395

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Belbasis L, Bellou V, Evangelou E, Ioannidis JP, Tzoulaki I. Environmental risk factors and multiple sclerosis: an umbrella review of systematic reviews and meta-analyses. Lancet Neurol. 2015;14:263-273
  2. Sawcer S, Franklin RJ, Ban M. Multiple sclerosis genetics. Lancet Neurol. 2014;13:700-709
  3. Katz Sand I. Classification, diagnosis, and differential diagnosis of multiple sclerosis. Curr Opin Neurol. 2015;28:193-205
  4. Comi G, Locatelli T, Leocani L, Medaglini S, Rossi P, Martinelli V. Can evoked potentials be useful in monitoring multiple sclerosis evolution? Electroencephalogr Clin Neurophysiol Suppl. 1999;50:349-357
  5. Lublin FD, Reingold SC, Cohen JA, et al. Defining the clinical course of multiple sclerosis: the 2013 revisions. Neurology. 2014;83:278-286
  6. Thompson AJ, Banwell BL, Barkhof F, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2018;17:162-173
  7. Giffroy X, Maes N, Albert A, Maquet P, Crielaard JM, Dive D. Do evoked potentials contribute to the functional follow-up and clinical prognosis of multiple sclerosis? Acta Neurol Belg. 2017;117:53-59
  8. Hardmeier M, Fuhr P. Multimodal Evoked Potentials as Candidate Prognostic and Response Biomarkers in Clinical Trials of Multiple Sclerosis. J Clin Neurophysiol. 2021;38:171-180
  9. Allen RP, Picchietti DL, Garcia-Borreguero D, et al. Restless legs syndrome/ Willis-Ekbom disease diagnostic criteria: updated International Restless Legs Syndrome Study Group (IRLSSG) consensus criteria--history, rationale, description, and significance. Sleep Med. 2014;15:860-873
  10. Giffroy X, Maes N, Albert A, Maquet P, Crielaard JM, Dive D. Multimodal evoked potentials for functional quantification and prognosis in multiple sclerosis. BMC Neurol. 2016;16:83
  11. Nuwer MR, Packwood JW, Myers LW, Ellison GW. Evoked potentials predict the clinical changes in a multiple sclerosis drug study. Neurology. 1987;37:1754-1761
  12. Leocani L, Guerrieri S, Comi G. Visual Evoked Potentials as a Biomarker in Multiple Sclerosis and Associated Optic Neuritis. J Neuroophthalmol. 2018;38:350-357
  13. Carter J, Stevens J. Somatosensory evoked potentials. In: Daube J, Rubin D, editors. Clinical Neurophysiology. New York: Oxford University Press; 2009. p. 257-280
  14. Invernizzi P, Bertolasi L, Bianchi MR, Turatti M, Gajofatto A, Benedetti MD. Prognostic value of multimodal evoked potentials in multiple sclerosis: the EP score. J Neurol. 2011;258:1933-1939
  15. Ramanathan S,